Malignancy Associated Microangiopathic Hemolytic Anemia and Thrombocytopenia

Abstract

Disseminated malignancy can rarely present with microangiopathic hemolytic anemia and thrombocytopenia clinically similar to thrombotic thrombocytopenic purpura (TTP), but does not respond to plasma exchange. TTP carries a grave prognosis if plasma exchange is delayed. Evaluating patients presenting with microangiopathic hemolytic anemia and thrombocytopenia is challenging for clinicians. Thrombotic thrombocytopenic purpura (TTP) should be considered in such patients and emergency plasma exchange is to be initiated. But all the clinical features seen in TTP can be caused by a disseminated malignancy. The awareness of such a rare presentation of disseminated malignancy helps clinicians to avoid unnecessary delay in appropriate treatment and the complications due to plasma exchange. We report two patients who presented with microangiopathic hemolytic anemia and thrombocytopenia due to disseminated malignancy.

Keywords

Disseminated malignancy - microangiopathic hemolytic anemia - thrombocytopenia - thrombotic thrombocytopenic purpura

• References

• 1 Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 2007; 12: 11-9
• 2 Kremer Hovinga JA, Vesely SK, Terrell DR, Lämmle B, George JN. Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010; 115: 1500-11
• 3 Francis KK, Kojouri K, George JN. Occult systemic malignancy masquerading as thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Community Oncol 2005; 2: 339-43
• 4 Elliott MA, Letendre L, Gastineau DA, Winters JL, Pruthi RK, Heit JA. et al. Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: An important diagnostic consideration. Eur J Haematol 2010; 85: 43-50
• 5 Oberic L, Buffet M, Schwarzinger M, Veyradier A, Clabault K, Malot S. et al. Cancer awareness in atypical thrombotic microangiopathies. Oncologist 2009; 14: 769-79
• 6 Werner TL, Agarwal N, Carney HM, Rodgers GM. Management of cancer-associated thrombotic microangiopathy: What is the right approach?. Am J Hematol 2007; 82: 295-8